Say No to a 'Dumb, Dangerous' Program

Nearly 7,000 research scientists at more than 110 physics, computer science, chemistry and other hard science departments at leading universities in the United States have signed a pledge to neither solicit nor accept funding from the Strategic Defense Initiative Organization (SDIO). This figure includes more than 3,800 senior faculty members and nearly 60 percent of the combined faculties of the top 20 physics departments in the country. Our position against SDI was summarized in a letter circu

Written byJohn Kogut
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

"The overriding reason for our boycott is that SDI will increase the chance of nuclear war and will offer only imaginary protection from its consequences. Space weapons would both threaten and invite a first strike. Possession of such space weapons by the United States and the Soviet Union would inexorably lead to nuclear war."

The Scientists Campaign Against the Strategic Defense Initiative has convinced many members of Congress and many concerned citizens that SDI is, in the words of Sheldon Glashow, one of the 21 Nobel laureates who have signed the pledge, "dumb, destabilizing and damned dangerous." Ninety-eight percent of the members of the National Academy of Sciences in fields relevant to SDI estimated that SDI could not provide an effective defense of the U.S. population if the Soviets try to overwhelm the defense.

The SDI was born in the inner circle of the Reagan White House. Retired Lt. Gen. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies